Clinical Trials Browser

Phase 2 × Lung Neoplasms × Hyaluronoglucosaminidase × Clear all

NCT05340309 2026-01-29

Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms